Filing Details
- Accession Number:
- 0001127602-13-011887
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-25 14:20:17
- Reporting Period:
- 2013-03-22
- Filing Date:
- 2013-03-25
- Accepted Time:
- 2013-03-25 14:20:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1376247 | Richard Mulligan | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-03-22 | 2,900 | $176.88 | 2,020 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.